IL24 and ovarian cancer: A recent study by Mahasreshti et al. [5] showed that targeted Ad-mda7 delivery can inhibit ovarian cancer growth and prolong the duration of animal survival when compared with that using a nontargeted adenoviral vector carrying the mda-7 gene.